Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

3 terminated/withdrawn out of 12 trials

Success Rate

72.7%

-13.8% vs industry average

Late-Stage Pipeline

17%

2 trials in Phase 3/4

Results Transparency

50%

4 of 8 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 4
2(50.0%)
4Total
N/A(2)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials
NCT02056834Completed

chronOS Inject in Proximal Tibial Fractures

Role: lead

NCT01288066Not ApplicableCompleted

Effectiveness of Hemi- Versus Total Shoulder Arthroplasty Using Implants of the "Epoca" System

Role: collaborator

NCT04576052Unknown

Long-term Coated and Non-coated Tibia Nails

Role: collaborator

NCT03635320Not ApplicableCompleted

The CHINA TFNA Study

Role: lead

NCT02203448Completed

Facet Wedge Post Market Study

Role: lead

NCT01048710Completed

Treatment of Medial Compartmental Osteoarthritis Grade 1-4 With TomoFix™ Small or Conservatively

Role: lead

NCT01847898Phase 4Completed

Study on the Treatment of Osteoporotic Vertebral Fractures Using Vertebral Body Stenting

Role: lead

NCT02656628Withdrawn

Observational Patient Registry of the Dynamic Locking Screws

Role: lead

NCT01132508Completed

Use of a Reinforced Injectable Calcium Phosphate Bone Cement in the Treatment of Tibial Plateau Fractures

Role: lead

NCT01282294Completed

Clinical Follow-up to Evaluate the Clinical Usefulness of Gentamicin-coated Titanium Nails in Tibia Fractures

Role: lead

NCT01282645Withdrawn

Case Series to Evaluate Patient Specific Implants (PSI) in Polyether Ether Ketone (PEEK) Performance After 2 Years

Role: lead

NCT01283737Phase 4Withdrawn

Use of Demineralised Bone Matrix (DBX) in Osteochondritis Dissecans (OCD)

Role: lead

All 12 trials loaded